|Day Low/High||48.74 / 49.40|
|52 Wk Low/High||42.40 / 66.53|
Before I bid everyone here at the Diary good day and plug into the earnings reports and corresponding conference calls I listed in my last post, here are some of the reports hitting the tape Thursday morning that I'll be watching and things I'll be ...
Altria's recent selloff should be welcomed by both value seekers and those desiring quarterly income to live on.
Any logical evaluation of this stock suggests low risk and tremendous upside.
Any logical evaluation of British American Tobacco suggests low risk and tremendous upside.
Canopy Growth's smoking engine won't necessarily ensure smooth sailing for Constellation.
What matters here is the ability to innovate, market, and sell.
Establishing who the stragglers are and what impact they might have in the future is the key at this point.
I'd be most interested in buying this name after a cap raise which I expect in the first quarter of 2019.
The buy-in from other companies into the space has been far larger.
After Altria's investment in Cronos Group, which cannabis company will be the next target?
Paul Simon was right about one thing. You know the nearer your destination, the more your slip slidin' away. The more markets slip on these awful days, the nearer we are getting to our destination. Is that a good thing? I think I'll stick to my defe...
The tobacco giant is being threatened on two fronts: e-cigarettes in the form of Juul and cannabis.
Here are 4 stocks that can be bought into the stock cyclone that might occur if things don't go the bulls way in the Argentine.
And keep in mind that earnings season is not over, and there's enough juice left to impact the marketplace.
It becomes difficult for me to tell you where to run in these markets...
Cannabis and tobacco are hard to equate, which Barclays' primer on the Cannabis industry misses.
Canopy Growth already has a $4 billion war chest thanks to Constellation Brands.
On Wednesday, Canada becomes the first major economy to legalize the recreational use of cannabis.
The time to scoop up Altria is now, not when some type of official announcement is made.
There are several avenues to invest in the potential cannabis boom -- recreational plays; medical plays; and companies that have a lot to gain from the industry but aren't reliant upon it for success.
The FDA seized "more than a thousand pages" of documents in a surprise inspection of e-cigarette maker Juul. Remember, FDA comments on the e-cigarette market in recent days were a positive for Big Tobacco stocks as any clampdown on e-cigs are though...
Ed Ponsi made an interesting comment this morning as he looked at shares of Tilray and Altria , and given my view that we are likely to see Big Tobacco be a player in the legal cannabis industry at some point, I wanted to touch on it. Ponsi's point...
Charts for the marijuana stock and the tobacco giant illustrate their different perception among traders.
These names all pay generous dividends and have limited China exposure.
Covered calls may be the best bet -- or wait for a dip.
Not every cannabis stock was strong on Wednesday. One significant Canadian name sure was though.
I'm stalking more favorable entry points for Altria Group and Toll Brothers; here's the plan.